Hospira Dacarbazine for Injection USP, 200 mg vial

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

dacarbazine, Quantity: 200 mg

متاح من:

Hospira Australia Pty Ltd

INN (الاسم الدولي):

Dacarbazine

الشكل الصيدلاني:

Injection, powder for

تركيب:

Excipient Ingredients: citric acid monohydrate; mannitol; citric acid; sodium hydroxide

طريقة التعاطي:

Intravenous

الوحدات في الحزمة:

1 x 20 mL pack

الفئة:

Medicine Listed (Export Only)

نوع الوصفة الطبية :

Not scheduled. Not considered by committee

الخصائص العلاجية:

Dacarbazine for Injection is indicated in the treatment of metastic malignant melanoma. In addition, its also indicated for Hodgkin's disease as a second line therapy when used in combination with other effective agents.

ملخص المنتج:

Visual Identification: A white or very pale yellow powder or plug; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

الوضع إذن:

Listed (Export Only)

تاريخ الترخيص:

2007-07-16